Streetbeat News

Marketing

COIN

MSTR

TSLA

The crypto market cap hits $2.5T with Bitcoin, Ethereum, Dogecoin surging as MicroStrategy buys more BTC. Tesla's German factory resumes after an arson attack. MILLI's value increases, outperforming Dogecoin and Shiba Inu. $47M stolen in crypto phishing in February. Bitcoin's volatility expected to decrease, while Ethereum's ETF approval odds drop. Ark Invest sells Coinbase shares despite Bitcoin's new highs. Tesla offers early Cybertruck delivery to long-term shareholders, and Volvo aims to cut EV charging times.

Portfolio Pulse from Akanksha Bakshi

March 12, 2024 | 4:04 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for March 12th, 2024, provides a trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, based on a proprietary formula considering price, volume, and options flow. It offers detailed analysis for each asset, predicting potential breakouts or reversals. The memo emphasizes the importance of the CPI data release and the Treasury's 10-Year Note Auction results on the Federal Reserve's rate decision. RIPS, a pro trader, curates the memo, offering insights and real-time mentorship to Market Clubhouse members.

Portfolio Pulse from RIPS

March 12, 2024 | 3:16 pm

AAPL

GOOG

VGT

XLK

Apple Inc is exploring AI-driven advertising in its App Store, testing an automated product similar to those of Alphabet Inc and Meta. This initiative, currently in a trial phase with select advertisers, aims to optimize ad placements across various formats, targeting specific audiences and regions. Apple's focus on AI and advertising, including potential expansions into Maps and Apple TV+, could significantly impact its revenue, with projections of $7 billion this year from advertising ventures. Investors can gain exposure to Apple through ETFs like Vanguard Information Tech ETF and SPDR Select Sector Fund - Technology.

Portfolio Pulse from Anusuya Lahiri

March 12, 2024 | 3:02 pm

BABA

EBIZ

ONLN

Alibaba Group Holding Ltd (NYSE:BABA) is investing approximately $640 million in Hong Kong's creative industries over the next five years, aiming to boost its media and entertainment division amidst intense competition. This follows a significant sales increase in its unit, attributed to China's strong box office performance. Alibaba is also enhancing staff incentives by merging stock options with cash rewards, starting April 1, 2024, to improve employee earnings' certainty and liquidity. The stock rose over 2% on Tuesday. Competitor JD.com Inc (NASDAQ:JD) increased salaries for its retail division last year. Alibaba can be accessed through ProShares Online Retail ETF (NYSE:ONLN) and Global X E-Commerce ETF (NASDAQ:EBIZ).

Portfolio Pulse from Anusuya Lahiri

March 12, 2024 | 2:43 pm

BTCUSD

ETHUSD

Tesla investor Ross Gerber advises against investing in lesser-known cryptocurrencies, emphasizing the value of Bitcoin and Ethereum amidst a significant rally in the crypto market. He highlights the failure rate of altcoin projects since 2020 but notes the recent Bitcoin rally could signal a broader market revival.

Portfolio Pulse from Benzinga Neuro

March 12, 2024 | 1:23 pm

SASI

Sigma Additive Solutions, Inc. (SASI) announced its corporate name change to NextTrip, Inc., effective March 13, 2024, following the acquisition of NextTrip Holdings, Inc. The company will start trading under the new ticker symbol 'NTRP' on the Nasdaq. This transition reflects its shift towards travel and travel media operations, leveraging partnerships with over 200 travel organizations and offering over 2 million hotels worldwide. NextTrip is preparing to launch its travel booking platform and a content ecosystem, including Compass.TV, to drive growth and shareholder value.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:15 pm

MGRX

Mangoceuticals, Inc. (NASDAQ:MGRX), also known as MangoRx, announced the launch of 'PRIME' by MangoRx, an FDA-approved oral testosterone replacement therapy (TRT). This product aims to target men currently on TRT or experiencing low testosterone symptoms, leveraging MangoRx's telehealth platform for distribution. The company plans to market PRIME to a significant addressable market, including those averse to injectable TRT, by utilizing social media influencers, celebrities, and athletes. PRIME's launch represents a strategic expansion into a new vertical with substantial market potential.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:09 pm

GLASF

GRAM

LEEEF

Benzinga's Elliot Lane discussed the California cannabis industry's challenges and opportunities on The Water Tower Hour podcast, highlighting insights from Benzinga's event in Los Angeles. Key topics included market navigation, operational excellence, and brand innovation with insights from Leef Brands, Glass House Brands, and Gold Flora Co. The discussion also previewed the upcoming Cannabis Capital Conference in Florida.

Portfolio Pulse from Patricio Liddle

March 12, 2024 | 1:08 pm

AAPL

META

Mark Zuckerberg, CEO of Meta Platforms Inc. (META), has countered claims by tech analyst Benedict Evans that Apple Inc.'s (AAPL) Vision Pro is similar to Meta's Quest lineup, emphasizing differences in product capabilities and vision. Zuckerberg highlighted the Quest's superiority in terms of weight, motion blur, and precision inputs, despite acknowledging Vision Pro's higher resolution. He also refuted the notion that VR headsets are solely for gaming, pointing out the outdated narrative and emphasizing the Quest's good resolution and other advantages.

Portfolio Pulse from Ananya Gairola

March 12, 2024 | 12:56 pm

MYNZ

Mainz Biomed N.V. (NASDAQ:MYNZ) announced its participation in the 39th UDH Congress 2024 in Germany, focusing on showcasing ColoAlert®, its flagship product for early colorectal cancer detection. ColoAlert® utilizes advanced tumor DNA analysis technology for high accuracy in CRC screening. The presentation at the UDH Congress is part of Mainz Biomed's strategy to promote evidence-based, innovative health solutions and foster collaboration across the health sector. The product is available in select EU countries and is pending FDA approval in the US.

Portfolio Pulse from Happy Mohamed

March 12, 2024 | 12:16 pm